doc. MUDr. Radomír Taláb, CSc.

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Multiple sclerosis

Running trials

• Active, not recruiting

  A Double-blind, Randomized, Active-controlled, Parallel-group, Phase 1/3 study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients with Relapsing-remitting Multiple Sclerosis.

  2022-501622-37-00· Phase 3· Celltrion Inc.· Source